The FDA recently approved tiotropium (Spiriva HandiHaler, Pfizer/Boehringer-Ingelheim) inhalation powder for the long-term, once-daily, maintenance treatment of bronchospasm associated with COPD, including bronchitis and emphysema. In the airways, tiotropium inhibits muscarinic (M3) receptors at the smooth muscle, leading to bronchodilation. The manufacturer anticipates that tiotropium will be available in pharmacies by mid-year.
What PhRMA plans to do in this presidential election year
Ertaczo is an antifungal used for the treatment of athlete's foot.
Debate shows pros and cons on the issue of drug reimportation
List of 85 drugs that were offered as generics for the first time in 2003
New low carb/no carb entries provide profitable niche for pharmacies
Some patients just won't listen to their pharmacist's advice when it conflicts with what they believe in
In the furor over drug counterfeiting, small wholesalers have ended up as tar babies
Breaking News for Feb. 9, 2004
The Medicare-endorsed discount card program is going to complicate state discount card programs
Medicaid prescription reimbursement rates by state --2003
NACDS and Express Scripts recently announced they are jointly seeking endorsement of a national Medicare discount card from CMS.
NCPA objects to cuts in payment for Medicare Part B drugs
States are up in the air about their discount card programs following the passage of the Medicare drug benefit legislation, which has a provision for an Rx card program
All eyes are glued to ACPE to see whether it will require national standards in tech education
More state pharmacy boards enacted various regulations governing pharmacy technicians last year, according to the 2003-2004 NABP Survey of Pharmacy Law.
Some experts believe that the pendulum has swung too far--not all drug errors should be blamed on systems
Archives of Neurology article offers recommendations for pharmacological management of neuropathic pain.
USP Drug Safety Review
Get set for new medication management standards from JCAHO
This installment discusses new frequently answered questions the government has just released
No numbers, no prescriptions
USP gives fourth annual report on its MEDMARX findings relative to drug errors reported by hospitals related to JCAHO's patient safety goals
Clinicians can now treat patients with bipolar depression using the first drug approved in the U.S. for this indication. The FDA recently approved olanzapine/fluoxetine (Symbyax, Eli Lilly) for the treatment of depressive episodes associated with bipolar disorder. Symbyax is currently available in pharmacies.
How hospitals are implementing damage control in the wake of a wave of drug errors
Following in the footsteps of Walgreens, CVS announced that it will not participate in future health plan contracts requiring refill scripts to be filled by mail order pharmacies.
More clients of pharmacy benefit managers are auditing their performance
stockchecker on incontinence
The main cause of patient not taking their medications is a breakdown in communications, according to a study by Cutting Edge Information.
Pharmacists and technicians are needed to staff 10 regionally based disaster response teams pharmacy organizations agreed to create to assist the Federal Emergency Management Agency.